Why drug-resistant typhoid needs to be considered a global problem
Typhoid fever, caused by Salmonella typhi, is a disease that was historically controlled through interventions in water and sanitation.[1] The bacteria’s developing resistance to a number of antibiotics, particularly in Asia, has led to the rise of multi-drug-resistant (MDR) and extensively drug-resistant (XDR) strains, escalating the threat.[2] The increasing resistance, especially in countries like India, poses a global health concern in the fight against antimicrobial resistance (AMR).
What is drug-resistant typhoid?[2]
The cause of drug-resistant typhoid fever is Salmonella typhi that has developed resistance to the antibiotics that are commonly used to treat this disease.
Historically, antibiotics like chloramphenicol and ampicillin were used to treat typhoid. Over time, Salmonella typhi strains that were resistant to these antibiotics started emerging. This was termed multidrug-resistance (MDR). MDR typhoid was widespread by the late 1980s and 1990s in Pakistan, India and Southeast Asian countries.
Eventually, this was followed by the emergence of extensively drug-resistant (XDR) strains of typhoid. XDR typhoid is resistant even to powerful antibiotics such as fluoroquinolones and third-generation cephalosporins. This resistance makes treatment much harder, raising concerns globally.
Why is drug-resistant typhoid a global threat
Rapid global spread
International travel and trade make it inevitable that regional strains of antibiotic-resistant typhoid will spread globally. Gaps in surveillance and underreporting of cases also contribute to the underestimation of drug-resistant typhoid. In 2021, nine XDR-typhoid cases were detected in the USA. These cases were not linked to travel, raising concerns about their spread.[1]
Declining treatment options
The rise of antimicrobial resistance (AMR) is significantly reducing treatment options. The misuse and overuse of antibiotics fuels resistance. The result is ineffective antibiotics across multiple drug classes, leaving doctors with very few options. In countries like India, where there is higher antibiotic consumption, there is an increased chance of facing serious health complications. Between the years 2000 and 2010, it is estimated that the use of antibiotics increased by 36% globally, and if resistance isn’t under control, it could lead to about 10 million deaths per year by 2050.[3]
Misdiagnosis and antibiotic misuse
Misdiagnosis and antibiotic misuse are major contributors to AMR. Often, illnesses like malaria or dengue are confused with typhoid, leading to unnecessary or improper antibiotic use. Combined with over-the-counter sales without appropriate prescriptions, the likelihood of resistance increases. This puts patients at risk and adds an additional strain on healthcare systems, making treatment more complicated. [3]
High disease burden
In India, typhoid remains a major public health challenge due to inadequate sanitation infrastructure and poor access to clean water. The rise of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Salmonella typhi strains has complicated treatment options, making treatment and management more difficult for healthcare providers. Children, who tend to be disproportionately affected, face higher fatality rates. The ongoing burden of disease places an immense strain on our healthcare systems, already grappling with limited resources.[3]
Climate and environmental factors
Urbanization and climate change are exacerbating the spread of typhoid. Rapid growth in urban spaces is outpacing sanitation infrastructure, while flooding and drought worsen access to clean water. As climate change increases storm events and disrupts water supply, it amplifies the risk of typhoid outbreaks.[1]
The impact on global public health
The rise of antimicrobial resistance (AMR) is a growing threat to global health, and India is not immune. Multidrug-resistant (MDR) typhoid, once primarily confined to regions in Pakistan, is now spreading to the US and the UK. In India, the lack of effective diagnostic tools and widespread antibiotic misuse are worsening the problem. As typhoid’s antibiotic resistance grows against critical medicines like azithromycin and cephalosporins, treatment options are rapidly diminishing. This could overburden India’s already strained healthcare system. If AMR continues to grow unchecked, resistant infections could become unmanageable.[3,4]
Why are current healthcare systems struggling?
The efforts to control typhoid are hindered by a lack of disease burden data. Blood culture, which is considered the gold standard, is expensive, intensive and lacks sensitivity, especially in low-resource settings. Moreover, asymptomatic carriers, who are unknowingly spreading infection, complicate control efforts. Improved early diagnostic tools, particularly accurate point-of-care tests, are urgently needed to combat the disease and eliminate transmission. The success of vaccination campaigns also relies on their ability to disrupt transmission by these carriers.[1]
What can be done to control drug-resistant typhoid?
Vaccination
Vaccination for typhoid is the most effective tool to control drug-resistance. The introduction of Typhoid Conjugate Vaccines (TCVs) is a game-changer, having shown strong protection against multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains. Studies have shown the effectiveness of TCV in preventing typhoid, with ongoing WHO recommendations to include it in routine immunisation schedules in endemic regions. With the rise of XDR, vaccination is a vital typhoid prevention and control strategy.[4]
Improve water and sanitation
Typhoid transmission is primarily linked to unsafe water and poor sanitation. The bacterial contamination of drinking water systems continues to fuel typhoid outbreaks in India. Inadequate water treatment systems and failing infrastructure in rapidly urbanising areas worsen the situation. A study showed how pipeline leaks, leading to sewage contamination, cause regular outbreaks. Addressing this issue requires comprehensive improvements in water treatment, sanitation and waste management.[5]
Better diagnostics and surveillance
Accurate and timely diagnosis is crucial for controlling drug-resistant typhoid. Blood test for typhoid is the gold standard, but is expensive. As a result, typhoid is often misdiagnosed or treated empirically with broad-spectrum antibiotics, worsening resistance. In India, the Widal test, which has low sensitivity, is widely used. This further complicates diagnosis. A systematic review of diagnostics highlighted the limitations of existing methods. The introduction of more accessible, rapid diagnostic tests (RDTs) can facilitate better diagnosis, reducing the overuse of antibiotics.[5]
Responsible antibiotic use
Misuse of antibiotics, including over-the-counter sales and improper prescribing, is a major contributor to antimicrobial resistance (AMR) in typhoid. Inappropriate antibiotic use has led to a rise in resistance, particularly to fluoroquinolones and third-generation cephalosporins. The growing resistance to azithromycin and the lack of effective oral antibiotics to treat drug-resistant typhoid highlight the need for stricter regulations. More awareness and education on correct antibiotic use are necessary. Incomplete treatment, such as stopping antibiotics before the course is finished, is one of the most preventable contributors to resistance.[3,5]
Conclusion
Drug-resistance is a growing global typhoid problem. This health threat affects countries across Asia, Africa and beyond. Rising antimicrobial resistance, poor sanitation, misuse of antibiotics and limited access to accurate diagnostics continue to fuel its spread. Without urgent action, treatment options may become even more limited in the future. Improving water and sanitation practices, encouraging proper hygiene practices, promoting responsible antibiotic use and investing in better surveillance systems are essential to control the disease. Vaccines remain one of the most effective ways to stay protected against antibiotic-resistant typhoid. Consult a doctor and ensure you and your family are appropriately vaccinated.
FAQs
What is drug-resistant typhoid?
Drug-resistant typhoid occurs when Salmonella typhi bacteria no longer respond to standard antibiotics, making treatment difficult.
Why is typhoid becoming resistant to antibiotics?
Typhoid becomes resistant due to overuse and misuse of antibiotics, enabling bacteria to develop resistance mechanisms over time.
How does typhoid spread globally?
Typhoid spreads through contaminated food and water. International travel, trade and migration contribute to its global spread.
What is XDR typhoid?
Can drug-resistant typhoid be prevented?
Drug-resistant typhoid can be prevented by vaccination, proper sanitation, clean water access and responsible antibiotic use.
Resources
Disclaimer: A public awareness initiative by Bharat Biotech International Limited. This information is for general awareness only and does not constitute medical advice. The doctors, medical facilities and graphics shown are for illustrative purposes only. For any medical advice or any question or concern you may have regarding your condition, consult your doctor.